Matthias Weissers Infopage  Vorträge   Beratung   Kontakt   
eintragen austragen   InterNetWORX
FreeFind
Gästebuch
   Seminare   Bücher   Infoletter  
Infopage | Medizin

 Matthias Weisser Logo Matthias Weisser's
alternative Medizin
Medizin-Banner
Hilfe 1 Psyche 2 Statik 3 Ernährung 4 Gifte 5 Zahnherde 6 Störfelder 7 Parasiten
8 heilende Informationen 9 Selbstheilung 10 Diagnostik 11 Zusammenhänge Literatur

Chelattherapie - zur Entgiftung - Literatur
Teil 1: Zusammenhänge
•  Symptome
•  Zusammenhänge
•  Therapieansätze
•  Erfolgsberichte bei Symptomen A-Z
Teil 2: Literaturhinweise zum Anklicken
Teil 3: Literaturhinweise Wissenschaft
siehe auch: Gifte/Entgiftung Klinghardt Detox Reinigung Clark-Tests
Wasser Fette/Öle Vitamin C Aminosäuren Koriander Licht Atmung Zetapotential

"1948 nutzen Detroiter Ärzte EDTA gegen Bleivergiftung..
Nebenwirkung besseres Seh- und Hörvermögen, weniger Anginaschmerzen (Angina pectoris),
können weitere Strecken laufen, weniger Krämpfe.. weniger Arteriosklerose.."

"ab 1958 zeigt die Studie von Dr. Walter Blumer und Elmer M. Cranton, daß
nahe einer Autostraße 90% weniger Patienten an Krebs sterben,
wenn mit EDTA entgiftet wird.." S.195-201 Cranton: 'A Textbook of EDTA Chelation Therapy'

"Dr. T.C. McDaniel: spezielle Infusionen verändern elektrische Bluteigenschaften
-> Blockaden und Mineralbeläge abbauen.. exzellente Resulate: keine amputierte Gliedmaßen.."

"Wer heilt, hat recht"

Literatur, Patente
  1905: Alfred Einhorn: Kokain-ähnliches nebenwirkungsfreies Narkosemittel Novocain=Procain
  1937: EDTA-Forschung IG-Farben
  US-Patent 2396938: Boilerreinigung mit EDTA. Bersworth 22.1.1944 -> 19.3.1946
  US-Patent 2564092: Chelatbildner. Bersworth 12.5.1948 -> 14.8.1951
  Morrison, Gonzalez: "Results of treatment of coronary arteriosclerosis with choline" Am Heart J 39,5 729-736 5.1950 Cholin gg. Koronararteriosklerose..
  Bessman, Ried, Rubin: "Treatment of lead encephalopathy with calcium disodium versenate: report of a case" Med Ann Dist Columbia 21,6 312-315 1952
  Rubin, Gignac, Bessman, Belknap: "Enhancement of lead excretion in humans by disodium calcium ethylenediamine tetraacetate" Science 117,3050 659-660 12.6.1953
  Byers, Maloof, De Simone, Morrell: "Edathamil calcium-disodium (versenate) in treatment of lead poisoning in children" Arch Pediatr Adolesc Med 87 559-569 1954
  Bessman, Layne: "Distribution of lead in blood as affected by edathamil calcium-disodium" Arch Pediatr Adolesc Med 89 292-294 1955
  Wade, Burnum: "Treatment of acute and chronic lead poisoning with disodium calcium versenate" Ann Intern Med 42 251-259 1955
  Markus, Spencer: "Treatment of chronic lead-poisoning with calcium disodium versenate" Br Med J 2,4944 883-885 8.10.1955 Fallgeschichten zur Bleientgiftung..
  Clarke, Clarke, Mosher: "The in vivo dissolution of metastatic calcium: an approach to atherosclerosis" Am J Med Sci 229,2 142-149 2.1955
  Clarke, Clarke, Mosher: "Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid" Am J Med Sci 232,6 654-666 12.1956 EDTA..
  O'Donohoe: "Lead poisoning in childhood treated by the subcutaneous administration of a chelating agent" Arch Dis Child 31,158 321-323 8.1956 Fallgeschichten zur Bleientgiftung bei Kindern..
  Loewe: "Vom Cocain zum Novocain" Arzneimittelforschung 6,1 43-50 1.1956
  Smith: "Lead poisoning in children and its therapy with EDTA" Ind Med Surg 28,3 148-151 1959 discussion 151-5 3.1959
  Jick, Karsh: "The effect of calcium chelation on cardiac arrhythmias and conduction disturbances" Am J Cardiol 4,3 287-293 9.1959
  Clarke, Clarke, Mosher: "Treatment of occlusive vascular disease with disodium ethylene diamine tetraacetic acid (EDTA)" Am J Med Sci 239 732-744 6.1960 EDTA erfolgreich gg. Arteriosklerose am Providence Hospital in Detroit..
  Clarke: "Atherosclerosis, occlusive vascular disease and EDTA" Am J Cardiol 6,2 233-236 8.1960 EDTA erfolgreich gg. Arteriosklerose am Providence Hospital in Detroit..
  Fürst: "Chelation and cancer - A speculative review" in Seven, Johnson: "Metal binding in medicine" Lippincott, Philadelphia 336-344 1960
  Kitchell, Meltzer, Seven: "Potential uses of chelation methods in the treatment of cardiovascular diseases" Prog Cardiovasc Dis 3 338-349 1.1961
  Meltzer, Kitchell, Palmon: "The long term use, side effects and toxicity of disodium ethylenediamine tetraacetic acid (EDTA)" Am J Med Sci 242,2 11-17 7.1961
  Foreman: "Use of chelating agents in treatment of metal poisoning (with special emphasis on lead)" Fed Proc 20,3 Pt 2 191-196 9.1961
  Boyle, Clarke, Mosher, McCann: "Chelation therapy in circulatory and sclerosing diseases" Fed Proc 20,3 Pt 2 243-252 9.1961
  Balmus, Nastac, Sandulesco: "L'action d'un produit chelateur. Le calciethylaminediaminetetraacetate disodique sur l'evolution du carcinome T8 Guerin chez le rat" Rev Path gen 61 423-433 1961
  Kitchell: "Peripheral flow opened up" Medical World News 4 36-39 15.3.1963
  Kitchell, Palmon, Aytan, Meltzer: "The treatment of coronary artery disease with disodium EDTA. A reappraisal" Am J Cardiol 11 501-506 4.1963
  Mokranjac, Petrovic: "Vitamin C as antidote in poisoning by fatal doses of mercury" C R Hebd Seances Acad Sci 258 1341-1342 27.1.1964 französisch..
  Lamar: "Chelation therapy of occlusive arteriosclerosis in diabetic patients" Angiology 15,9 379-395 1.9.1964
  Lamar: "Chelation endarterectomy for occlusive atherosclerosis" J Am Geriatr Soc 14,3 272-294 3.1966
  Morrison, Murata, Quilligan, Schjeide, Freeman: "Prevention of atherosclerosis in sub-human primates by chondroitin sulfate A" Circ Res 19 358-363 8.1966 Prävention Arteriosklerose durch Chondroitin-Sulfat..
  US-Patent 3351658: Chelatbildner. Bersworth 6.4.1965 -> 7.11.1967
  US-Patent 3565813: Chelatbildner. Bersworth 2.10.1967 -> 23.2.1971
  Olwin, Koppel: "Reduction of elevated plasma lipid levels in atherosclerosis following EDTA therapy" Proc Soc Exp Biol Med 128 1137-1140 1968
  Riddick: "Control of Colloid Stability through Zeta Potential. With a closing chapter on its relationship to cardiovascular disease" 1968.. Krankheiten durch Zerstören des Zetapotentials.. Herzprobleme, Durchblutungsstörungen heilbar durch spezielle Elektrolyte auf Basis von destilliertem Wasser..
  Riddick: "Control of colloid stability through zeta potential" Library of Congress Catalogue Number 67-18001 1968
  Roosels: "An atomic absorption determination of lead in urine after extraction with dither" Atom Abscam Newsweek 7 9-10 1968
  Morrison: "Treatment of coronary arteriosclerotic heart disease with chondroitin sulfate-A: preliminary report" J Am Geriatr Soc 16,7 779-785 7.1968 Chondroitin-Sulfat gegen Arteriosklerose..
  Morrison, Rucker, Ershoff: "Prolongation of thrombus-formation time in rabbits given chondroitin sulfate A" J Atheroscler Res 8,2 319-327 1968 Chondroitin-Sulfat reduziert Thrombus-Bildung..
  Izuka, Murata, Nakazawa, Okubo, Oshima: "Effects of chondroitin sulfates on serum lipids and hexosamines in atherosclerotic patients: with special reference to thrombus formation time" Jpn Heart J 9,5 453-460 9.1968 Chondroitin-Sulfat reduziert Thrombus-Bildung..
  Nakazawa, Murata, Izuka, Oshima: "The short-term effects of chondroitin sulfates A and C on coronary atherosclerotic subjects: With reference to its anti-thrombogenic activities" Jpn Heart J 10,4 289-296 7.1969 Chondroitin-Sulfat reduziert Thrombus-Bildung..
  Morrison, Branwood, Ershoff, Murata, Quilligan, Schjeide, Patek, Bernick, Freeman, Dunn, Rucker: "The prevention of coronary arteriosclerotic heart disease with chondroitin sulfate A: preliminary report" Exp Med Surg 27,3 278-289 1969 Chondroitin-Sulfat verhindert Arteriosklerose..
  Morrison: "Response of ischemic heart disease to chondroitin sulfate-A" J Am Geriatr Soc 17,10 913-923 10.1969 Chondroitin-Sulfat bei Herzkrankheit..
  Barth, Mikalis, Harris, Bruckner: "Evaluation of clays as binding agents for reduction of radionuclides in milk. Effect of Belle Fourche Betonite on excretion in lactating goats" J Agr Food Chem 17 1347-1349 1969
  Wobeser: "Apparent favorable response of lead poisoning in a duck to treatment with a chelating agent" Wildl Dis 5,2 120 4.1969
  Blumer: "Bleidepots bei Anwohnern einer Autostrasse" Med Neuheiten 75 3-8 6.1969
  Morrison, Bajwa, Ershoff: "Prolongation of the plasma thrombus formation time of dogs administered chondroitin sulfates A and C" Exp Med Surg 28,2 188-193 1970 Chondroitin-Sulfat reduziert Thrombus-Bildung..
  Blumer: "Nervöse Störungen durch Autoabgase" Praxis 59 1809-1816 1970
  Morrison: "Reduction of ischemic coronary heart disease by chondroitin sulfate A" Angiology 22,3 165-174 3.1971 Chondroitin-Sulfat bei koronarer Herzkrankheit..
  Blumer, Jaumann, Reich: "Motorisierung wichtigste Ursache für Krebsentstehung?" Praxis 61 514-518 1972
  Morrison, Bajwa, Alfin-Slater, Ershoff: "Prevention of vascular lesions by chondroitin sulfate A in the coronary artery and aorta of rats induced by a hypervitaminosis D, cholesterol-containing diet" Atherosclerosis 16,1 105-118 1972 Chondroitin-Sulfat verhindert Arteriosklerose..
  Morrison, Bajwa: "Absence of naturally occurring coronary atherosclerosis in squirrel monkeys (Saimiri sciurea) treated with chondroitin sulfate A" Experientia 28,12 1410-1411 15.12.1972 Chondroitin-Sulfat verhindert Arteriosklerose..
  Morrison, Enrick: "Coronary heart disease: reduction of death rate by chondroitin sulfate A" Angiology 24,5 269-287 5.1973 Chondroitin-Sulfat reduziert Sterblichkeit..
  Apffel, Walker, Issarescu: "Tumor rejection in experimental animals treated with radioprotective thiols" Cancer Res 35 429-437 1975
  Kallistratos: "Verhinderung der 3,4-Benzopyren-Kanzerogenese durch natürliche und synthetische Verbindungen" Münchner med Wochenschr 117 391-394 1975
  Blumer, Reich: "Bleibenzin und Krebsmortalität" Schweiz med Wochenschr 106 503-506 1976
  Knutti, Schlatter: "Motorisierung und Krebsgefährdung" Schweiz med Wochenschr 107 312-315 1977
  Blumer, Blumer, Reich: "Polycyclic aromatic hydrocarbons in soils of a mountain valley: Correlation with highway traffic and cancer incidence" Envir Sci Technol 11 1082-1084 1977
  Grant, Zucker: "EDTA-induced increase in platelet surface charge associated with the loss of aggregability. Assessment by partition in aqueous two-phase polymer systems and electrophoretic mobility" Blood 52,3 515-523 9.1978
  Nakazawa, Murata: "Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects" Z Alternsforsch 34,2 153-159 1979 Chondroitin-Sulfat reduziert Arteriosklerose, Sterblichkeit, weniger Cholesterin..
  Blumer, Reich: "Leaded gasoline - a cause of cancer" Environmental International 3 465-471 1980
  Casdorph: "EDTA chelation therapy: efficacy in arteriosclerotic heart disease" J Hol Med 3 53-59 1981 Tabelle mit statistisch signifikanten Verbesserungen durch EDTA..
  Casdorph: "EDTA chelation therapy II: efficacy in brain disorders" J Hol Med 3 101-117 1981 Tabelle und Bilder..
  McDonagh, Rudolph, Cheraskin: "Serum cholesterol and the aging process" Med Hypotheses 7 685-694 1981
  McDonagh, Rudolph, Cheraskin: "The effect of intravenous disodium ethylene diamine tetraacetic acid (EDTA) upon blood cholesterol in a private practice environment" J Int Acad Prev Med 7 5-12 1982
  McDonagh, Rudolph, Cheraskin: "An oculocerebrovasculometric analysis of the improvement in arterial stenosis following EDTA chelation therapy" J Hol Med 4 21-23 1982
  McDonagh, Rudolph, Cheraskin: "The influence of EDTA salts plus multivitamin-trace mineral therapy upon total serum cholesterol/high-density lipoprotein cholesterol" Med Hypotheses 9,6 643-646 12.1982
  McDonagh, Rudolph, Cheraskin: "The effect of EDTA chelation therapy plus supportive multivitamin trace mineral supplementation upon renal function: a study in serum creatinine" J Hol Med 4 146-151 1982
  Kohn: "Binding of toxic cations to pectin, its oligomeric fragments and plant tissues" Carbohydr Polym 2,4 273-275 1982
  Rudolph, McDonagh: "The chelation carrier solution: an analysis of osmolarity and sodium content" J Int Acad of Prev Med 8,1 26-34 1983 weniger Stenosen nach Therapie..
  McDonagh, Rudolph, Cheraskin: "The nutrition-prevention connection" Osteopathic Annals 11,3 109-115 3.1983 weniger Stenosen nach Therapie..
  McDonagh, Rudolph, Cheraskin: "The effect of EDTA chelation therapy plus supportive multivitamin - trace mineral supplementation upon renal function: a study in blood urea nitrogen (BUN)" J Hol Med 5 163-171 1983
  McDonagh, Rudolph, Cheraskin: "The effect of intravenous disodium ethylenediaminetetraacetic acid (EDTA) plus supportive multivitamin/trace mineral supplementation upon fasting serum calcium" Med Hypotheses 11,4 431-438 8.1983
  Casdorph: "EDTA chelation therapy, efficacy in arteriosclerotic heart disease and brain disorders" J Chronic Disease and Therapeutic Research 7 105-115 1983
  Casdorph, Farr: "EDTA chelation therapy III: treatment of peripheral arterial occlusion: an alternative to amputation" J Hol Med 5 3-15 1983
  Cranton, Frackelton: "Free radical pathology in age-associated diseases: treatment with EDTA chelation, nutrition, and antioxidants" J Hol Med 6 6-37 1984
  McDonagh, Rudolph, Cheraskin, Wussow: "The effect of EDTA and supportive multivitamin/trace mineral supplementation with and without physical activity upon systolic blood pressure" J Orthomol Psychiat 13 1-9 1984
  McDonagh, Rudolph, Cheraskin: "The effect of EDTA chelation therapy with multivitamin/trace mineral supplementation upon reported fatigue" J Orthomol Psychiatry 13,4 277-279 1984
  Cheraskin, Wussow, McDonagh, Rudolph: "Effect of EDTA chelation and supportive multivitamin/trace mineral supplementation with and without physical activity on the heart rate" J Int Academy of Preventive Medicine 8,6 5-9 11.1984
  Sehnert, Clague, Cheraskin: "The improvement in renal function following EDTA chelation and multi-vitamin-trace mineral therapy: a study in creatinine clearance" Med Hypotheses 15,3 301-304 11.1984
  McDonagh, Rudolph, Cheraskin: "The clinical change in patients treated with EDTA chelation plus multivitamin/trace mineral supplementation" J Orthomol Psychiatry 14,1 61-65 1985
  McDonagh, Rudolph, Cheraskin: "The psychotherapeutic potential of EDTA chelation" J Orthomol Psychiatry 14,3 214-217 1985
  McDonagh, Rudolph, Cheraskin: "The effect of EDTA chelation therapy plus multivitamin/trace mineral supplementation upon vascular dynamics (ankle/brachial systolic blood pressure)" J Hol Med 7,1 16-22 1985
  McDonagh, Rudolph, Cheraskin: "The 'clinical change' in patients treated with EDTA chelation plus multivitamin/trace mineral supplementation" J Orthomol Psychiatry 14,1 61-65 1985
  Stevens, Beasley, Blumberg: "Iron binding proteins and risk of cancer in Taiwan" JNCI 76 605-610 1986
  Selby, Friedmann: "Epidemiologic evidence of an association between body iron stores and risk of cancer" Int J Cancer 41,5 677-682 15.5.1988 weniger Lungenkrebs bei Frauen durch Eisengabe..
  Stevens, Jones, Micozzi, Taylor: "Body iron stores and the risk of cancer" N Engl J Med 319,16 1047-1052 20.10.1988 mehr Eisen -> mehr Krebs..
  Olszewer, Carter: "EDTA chelation therapy in chronic degenerative disease" Med Hypotheses 27,1 41-49 9.1988
  Rudolph, McDonagh, Wussow: "The effect of intravenous disodium ethylenediaminetetraacetic acid (EDTA) upon bone density levels" J Adv Med 1,2 79-85 1988
  Blumer, Cranton: "Ninety percent reduction in cancer mortality after chelation therapy with EDTA" J Adv Med 2,1-2 183-187 1989
  Blumer, Cranton: "Ninety percent reduction in cancer mortality after chelation therapy with EDTA" in "A textbook on EDTA chelation therapy" Chapter 12 195-201 1989 90% weniger Krebssterblichkeit durch Entgiftung..
  Rudolph, McDonagh, Barber: "Effect of EDTA chelation and supportive multivitamin/trace mineral supplementation on chronic lung disorders: a study of FVC and FEV" J Adv Med 2,4 553-561 1989
  Olszewer, Carter: "EDTA chelation therapy: a retrospective study of 2870 patients" J Adv Med 2 197-211 1989 2870 Patienten mit Arteriosklerose etc. -> Disodium EDTA Chelation Therapie.. ischämische Herzkrankheit: deutlich verbessert 76.9%, gut verbessert 17%.. periphere Verschlusskrankheit: 91% und 8%.. Hirndurchblutung: 24% und 30%.. insgesamt hatten 89% einen Nutzen.. in "A Textbook on EDTA Chelation Therapy, Second Edition"..
  Olszewer, Sabbag, Carter: "A pilot double-blind study of sodium-magnesium EDTA in peripheral vascular disease" J Natl Med Assoc 82,3 173-177 3.1990
  Cheraskin: "The psychotherapeutic potential of EDTA chelation" J Orthomol Psychiatry 5,4 215-218 1990
  Rudolph, McDonagh: "Effect of EDTA chelation and supportive multivitamin trace mineral supplementation on carotid circulation: case report" J Adv Med 3,1 5-11 1990
  Rudolph, McDonagh, Barber: "An observation of the effect of EDTA chelation and supportive multivitamin/trace mineral supplementation on blood platelet volume: a brief communication" J Adv Med 3,3 179-184 1990
  Rudolph, McDonagh, Barber: "Effect of EDTA chelation on serum iron" J Adv Med 4,1 39-45 1991
  Rudolph, McDonagh, Barber: "A nonsurgical approach to obstructive carotid stenosis using EDTA chelation" J Adv Med 4,3 157-166 1991
  Sloth-Nielson, Guldager, Mouritzen, Mouritzen, Lund, Egeblad, Norregaard, Jorgensun, Jelnes: "Arteriographic findings in EDTA chelation therapy on peripheral arteriosclerosis" Am J Surg 162 122-125 1991
  McDonagh, Rudolph: "Effects of EDTA chelation on chronic degenerative diseases" J Neurol Orthop Med Surg 1992
  Guldager, Jelnes, Jorgensen et al: "EDTA treatment of intermittent claudication - a double blind, placebo-controlled study" J Intern Med 231 261-267 1992
  Wegmann: "Chelation therapy to treat lead toxicity in children" Minn Med 75,11 25-27 11.1992
  Chisolm: "BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children" J Toxicol Clin Toxicol 30,4 493-504 1992
  Hancke, Flytlie: "Benefit of EDTA chelation therapy in arteriosclerosis: A retrospective study of 470 patients" J Adv Med 6,3 161-171 1993
  Chappell, Stahl: "The correlation between EDTA chelation therapy and improvement in cardiovascular function: a meta-analysis" J Adv Med 6,3 139-160 1993
  Mortensen, Walson: "Chelation therapy for childhood lead poisoning. The changing scene in the 1990s" Clin Pediatr 32,5 284-289 5.1993
  van Rij, Solomon, Packer, Hopkins: "Chelation therapy for intermittent claudication, a double blind, randomized, controlled trial" Circulation 90,3 1194-1199 1994
  Rudolph, Samuels, McDonagh: "Visual field evidence of macular degeneration reversal using a combination of EDTA chelation and multiple vitamin and trace mineral therapy" J Adv Med 7,4 203-212 1994
  Sorenson, Soderberg, Chang: "Radiation protection and radiation recovery with essential metalloelement chelates" Proc Soc Exp Biol Med 210,3 191-204 1995
  Pienta, Naik, Akhtar, Yamazaki, Replogle, Lehr, Donat, Tait, Hogan, Raz: "Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin" J Natl Cancer Inst 87,5 348-353 1.3.1995 Metastasen hemmen durch modifiziertes Citrus-Pektin..
  Holliday: "Carotid restenosis: a case for EDTA chelation" J Adv Med 9,2 95-99 1996
  Chappell, Janson: "EDTA chelation therapy in the treatment of vascular disease" J Cardiovasc Nurs 10,3 78-86 4.1996
  Chappell: "Applications of EDTA chelation therapy" Alt Med Review 2 426-432 1997
  Rozema: "The protocol for the safe and effective administration of EDTA and other chelating agents for vascular disease, degenerative disease, and metal toxicity" J Adv Med 10,1 5-100 1997
  Ali, Ali, Fayemi, Juco, Grieder-Brandenburger: "Improved myocardial perfusion in patients with advanced ischemic heart disease with an integrative management program including EDTA chelation therapy" J Integrative Medicine 1,1 113-142 1997 61% sehr gut, 17% gut, 13% mittel, 9% schwach..
  Fisher, Le Couteur: "Lead poisoning from complementary and alternative medicine in multiple sclerosis" J Neurol Neurosurg Psychiatry 69,5 687-689 11.2000 Verbesserung durch Chelat-Therapie..
  Hayashi, Gillen, Lott: "Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice" Altern Med Rev 5,6 546-552 12.2000 Quercetin und modifiziertes Zitrus-Pektin gegen Darmkrebs..
  Authier, Cherin, Creange et al: "Central nervous system disease in patients with macrophagic myofasciitis" Brain 124,Pt 5 974-983 5.2001 Nervenerkrankung durch Aluminium in Impfstoffen..
  Cremin, Luck, Laughlin, Smith: "Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys" Environ Health Perspect 109,6 613-619 6.2001 DMSA bei Bleivergiftung.. gute Literaturliste..
  Waters, Bryden, Patterson, Veillon, Anderson: "EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc" Biol Trace Elem Res 83,3 207-221 12.2001
  Shannon, Woolf, Binns: "Chelation therapy in children exposed to lead" N Engl J Med 345,16 1212-1213 18.10.2001
  Knudston, Wyse, Galbraith et al: "Chelation therapy for ischemic heart disease, a randomized controlled trial" JAMA 287,4 481-486 2002
  Nangia-Makker, Hogan, Honjo, Baccarini, Tait, Bresalier, Raz: "Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin" J Natl Cancer Inst 94,24 1854-1862 18.12.2002 Hemmung Krebswachstum durch modifiziertes Zitrus-Pektin..
  Guess, Scholz, Strum, Lam, Johnson, Jennrich: "Modified citrus pectin (MCP) increases the prostate-specific antigen doubling time in men with prostate cancer: a phase II pilot study" Prostate Cancer Prostatic Dis 6,4 301-304 2003 modifiziertes Zitrus-Pektin MCP gegen Prostatakrebs..
  Schober, Sinks, Jones, Bolger, McDowell, Osterloh, Garrett, Canady, Dillon, Sun, Joseph, Mahaffey: "Blood mercury levels in US children and women of childbearing age, 1999-2000" JAMA 289,13 1667-1674 2.4.2003 8% der Frauen hatten zu viel Quecksilber im Blut..
  Flora, Pande, Mehta: "Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication" Chem Biol Interact 145,3 267-280 15.6.2003
  Dietrich, Ware, Salganik, Radcliffe, Rogan, Rhoads, Fay, Davoli, Denckla, Bornschein, Schwarz, Dockery, Adubato, Jones: "Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry" Pediatrics 114,1 19-26 7.2004 scheinbar kein Effekt bei weniger Blei im Blut..
  Eliaz, Hotchkiss, Fishman, Rode: "The effect of modified citrus pectin on urinary excretion of toxic elements" Phytother Res 20,10 859-864 10.2006 modifiziertes Zitrus-Pektin entgiftet.. Arsen, Cadmium, Blei..
  Gracia, Snodgrass: "Lead toxicity and chelation therapy" Am J Health Syst Pharm 64,1 45-53 1.1.2007 Entgiftung problematisch.. meistens mit Dimercaprol, edetate calcium disodium, succimer..
  Ionescu, Novotny, Stejskal, Lätsch, Blaurock-Busch, Eisenmann-Klein: "Übergangsmetalle in der Pathogenese des Mammakarzinoms" OM & Ernährung 121 2007 Schwermetalle als Faktor bei Brustkrebs..
  Eliaz, Weil, Wilk: "Integrative medicine and the role of modified citrus pectin/alginates in heavy metal chelation and detoxification - five case reports" Forsch Komplementmed 14,6 358-364 12.2007 modifiziertes Zitrus-Pektin entgiftet.. im Mittel 74% Schwermetallreduzierung ohne Nebenwirkungen.. MCP verhindert Tumorzellembolie, Metastasen, reduziert Tumorwachstum, verlangsamt Prostatakrebs, unterstützt das Immunsystem.. bindet Schwermetalle wie Quecksilber und leitet aus ohne wichtige Mineralstoffe anzugreifen.. 35 Jahre Alginate zur Entgiftung und gg. Strahlenschäden, zur Wasser- und Ölreinigung.. 5 Fallberichte..
  Modi, Flora: "Combined administration of iron and monoisoamyl-DMSA in the treatment of chronic arsenic intoxication in mice" Cell Biol Toxicol 23,6 429-443 11.2007
  Zhao, Liang, Fan, Yu, Hotchkiss, Wilk, Eliaz: "The role of modified citrus pectin as an effective chelator of lead in children hospitalized with toxic lead levels" Altern Ther Health Med 14,4 34-38 2008 modifiziertes Zitrus-Pektin entgiftet wirksam Blei..
  Atwood, Woeckner, Baratz, Sampson: "Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned" Medscape J Med 10,5 115 13.5.2008 harte Kritik an Chelattherapie.. als krimineller Unsinn abgetan.. interessant aufgrund der vielen wertvollen Quellenangaben..
  Vogt: "Lead for car batteries poisons an african town" Hindustan Times, Mumbai 5.1.2009 Bleivergiftung durch Bleibatterien in Tyiaroye Sur Mer, Senegal..
  Glinsky, Raz: "Modified citrus pectin anti-metastatic properties: one bullet, multiple targets" Carbohydr Res 344,14 1788-1791 28.9.2009 modifiziertes Zitrus-Pektin MCP gegen Metastasen..
  Bradberry, Vale: "A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning" Clin Toxicol 47,9 841-858 11.2009
  Loeprich: "Mit EDTA-Chelat-Therapie der Krebsentstehung vorbeugen" CoMed 10.2009 Studie Blumer&Cranton zeigt Krebssterblichkeit -90% durch EDTA-Behandlung..
  Yan, Katz: "PectaSol-C modified citrus pectin induces apoptosis and inhibition of proliferation in human and mouse androgen-dependent and -independent prostate cancer cells" Integr Cancer Ther 9,2 197-203 6.2010
  Blaurock-Busch, Amin, Rabah: "Heavy metals and trace elements in hair and urine of a sample of arab children with autistic spectrum disorder" Maedica 6,4 247-257 2011
  Fulgenzi, Zanella, Mariani, Vietti, Ferrero: "A case of multiple sclerosis improvement following removal of heavy metal intoxication: lessons learnt from Matteo's case" Biometals 25,3 569-576 6.2012 EDTA setzt verstärkt Aluminium, Blei, Quecksilber im Urin frei.. verbesserte Symptome..
  Jacobi-Gresser, Huesker, Schütt: "Genetic and immunological markers predict titanium implant failure: a retrospective study" Int J Oral Maxillofac Surg 24.8.2012 Titan-Implantate können Probleme verursachen..

© 2000-2018 Weisser
Impressum
email www.gesundohnepillen.de